Delayed Puberty
Delayed puberty is the absence of any signs of pubertal development at an age where it is expected to have begun. In the UK, this is defined as a lack of testicular enlargement (testicular volume of 4 ml or more) by age 14 in boys, or the absence of breast development (Tanner stage B2) by age 13 in girls. While most cases are a normal variant of development, a thorough assessment is crucial to rule out a pathological cause.
Aetiology and Classification
Delayed puberty can be classified into two main categories:
Constitutional Delay of Growth and Puberty (CDGP): This is the most common cause. It’s a normal variant where the hypothalamic-pituitary-gonadal (HPG) axis is fully functional but matures later than average. These children have delayed bone age but a normal height velocity for their bone age and will eventually achieve normal adult height.
Hypogonadism: This is a pathological cause where the HPG axis is not functioning correctly.
Hypergonadotropic Hypogonadism: This is a primary failure of the gonads to produce sex hormones. Gonadotropin levels (LH and FSH) are high.
Boys: Klinefelter syndrome (47, XXY) or testicular damage from chemotherapy, radiotherapy, or trauma.
Girls: Turner syndrome (45, X) or ovarian damage.
Hypogonadotropic Hypogonadism: This is a central failure of the hypothalamus or pituitary gland to produce GnRH, LH, and FSH. Gonadotropin levels are low.
Isolated GnRH deficiency: Can be sporadic or syndromic (e.g., Kallmann syndrome, which also has anosmia or hyposmia).
Hypothalamic-Pituitary Disorder: Tumours (e.g., craniopharyngioma), cranial radiotherapy, or chronic systemic illnesses.
Clinical Assessment
History
Growth: A key part of the history is to review previous growth charts and assess the child’s height velocity.
Family History: A family history of delayed puberty (e.g., a father who had a late growth spurt) strongly suggests a diagnosis of CDGP.
Systemic Symptoms: Ask about any symptoms of an underlying chronic illness (e.g., weight loss, fatigue) or intracranial pathology (e.g., headaches, visual disturbances).
Examination
Accurate Measurements: Plot height and weight on a growth chart and calculate the mid-parental height.
Pubertal Staging: Use Tanner staging to assess the presence and progression of puberty. In boys, measure testicular volume using an orchidometer. A volume of less than 4 ml is prepubertal.
Systemic Exam: Perform a full systemic examination to look for signs of a chronic illness.
Dysmorphic Features: Look for any syndromic features, such as those seen in Turner syndrome (e.g., short stature, webbed neck).
Investigations
First-line:
Bone Age: An X-ray of the left wrist is a key investigation. A delayed bone age is a characteristic feature of CDGP.
Endocrine Bloods: Baseline blood tests should include LH, FSH, TSH, and T4.
Further Investigations:
Karyotype: A karyotype should be considered in girls with short stature and suspected delayed puberty to rule out Turner syndrome.
GnRH Stimulation Test: A key test to differentiate between CDGP and hypogonadotropic hypogonadism. In CDGP, the pituitary will respond to GnRH, while in hypogonadotropic hypogonadism, it will not.
MRI Brain: An MRI of the brain is required if there are any signs of intracranial pathology or if hypogonadotropic hypogonadism is diagnosed to rule out a tumour.
Management
CDGP:
Reassurance: The primary management is reassurance to the child and family that this is a normal variant and that puberty will occur naturally.
Hormone Therapy: A short course of sex hormone therapy may be considered in severe cases for a psychological boost, but it does not change the final adult height.
Hypogonadism: Management is directed at the underlying cause.
Hormone Replacement: Long-term hormone replacement therapy is required to induce puberty and maintain secondary sexual characteristics.
Tumours: Tumours will require surgical or medical management.
